Join to access to all OVN content. Join for Free
How to Architect a Presentation for an MSL Interview
Medical Science Liaisons MSL interview presentations virtual presentations crafting compelling narratives mastering Q&A session

How to Architect a Presentation for an MSL Interview


Share This Article


Summary

In this episode, Tom Caravela welcomes guests Kendra Peltz and Josh Yoder, who share their unique journeys from wrestling backgrounds to becoming Medical Science Liaisons. They delve into the intricacies of MSL interview presentations, offering insights on preparation and execution. Kendra discusses her approach to creating impactful presentations, while Josh shares tips on crafting compelling narratives. The conversation covers the importance of following interview instructions, choosing the right topics, and mastering the Q&A session. The episode wraps up with advice for virtual presentations and a preview of future topics, encouraging listeners to subscribe for more insights.

My guests today are Josh Yoder, Regional Director and Kendra Pelz, MSL at Syneos Health and we discuss how to "architect" a presentation for an MSL interview

Josh and Kendra share…

๐Ÿ‘‰ Types of presentations companies typically request
๐Ÿ‘‰ Summary of Kendra’s presentation process for her last interview
๐Ÿ‘‰ A framework for an interview presentation
๐Ÿ‘‰ Types of questions that can be expected during the Q&A portion
๐Ÿ‘‰ Tips on how to stand out in your presentation

Click for Source
Medical Science Liaisons, MSL interview presentations, virtual presentations, crafting compelling narratives, mastering Q&A session

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%โ€‹
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%โ€‹

Explore OVN